Skip to main content

AN 446 (Entecavir 0.5 mg)

Pill with imprint AN 446 is White, Elliptical/Oval and has been identified as Entecavir 0.5 mg. It is supplied by Amneal Pharmaceuticals of New York, LLC.

Entecavir is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Entecavir 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for AN 446


AN 446
0.5 mg
10.00 mm
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Amneal Pharmaceuticals of New York, LLC
Inactive Ingredients
lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone, hypromelloses, polyethylene glycol 8000, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
65162-0446 (Discontinued) Amneal Pharmaceuticals LLC
42291-0261 (Discontinued) AvKare, Inc.
10135-0615 Marlex Pharmaceuticals Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.